Dame Emma joined the board as CEO designate in January 2017 and officially became CEO in April 2017. She has been part of GSK’s leadership team since 2011, initially serving as president and then CEO of GSK Consumer Healthcare, where she played a key role in shaping the joint venture between GSK and Novartis. Prior to GSK, she spent 17 years at L’Oréal, holding leadership roles in Paris, London, New York and Shanghai. Her extensive experience in global business and consumer healthcare has positioned her as a transformational leader in the industry. Additionally, as an independent director of Microsoft, Inc., she brings valuable expertise in technology and cybersecurity to the board.
